The multiple acyl-coenzyme A (CoA) dehydrogenation disorders (MAD) include severe (S) and mild (M) variants, glutaric aciduria type II (MAD:S) and ethylmalonic-adipic aciduria (MAD:M).
Introduction
The multiple acyl-coenzyme A (CoA)' dehydrogenation disorders (MAD) include severe (S) and mild (M) variants, termed glutaric aciduria type II and ethylmalonic-adipic aciduria/mild glutaric aciduria type II, respectively. First described in 1976 (1), glutaric aciduria type II (MAD:S) is an inborn error of me-(2-4). First, they are all dethiolated acyl-CoA's or direct derivatives ofthese acyl-CoA's. Second, the first step in the catabolism of all these acyl-CoA's is dehydrogenation at carbons 2 and 3 in the mitochondrial matrix. These two characteristics, coupled with the results of radiolabeled substrate oxidation studies in vitro (1, 8, 15, 16, 22, 23) , suggest that enzymatic dehydrogenation of multiple acyl CoA's is functionally deficient in these disorders.
It has been postulated that the MAD are caused by deficient electron transfer from the flavin adenine dinucleotide (FAD)-requiring acyl-CoA dehydrogenases (ADH) to the ubiquinone (CoQ10) ofthe electron transport chain (2-4, 22, 24) . The electron transfer flavoprotein (ETF) and the iron-sulfur flavoprotein, ETF dehydrogenase (ETF-DH; ETF:ubiquinone oxidoreductase) mediate this sequential transfer of electrons (Fig. 1) . Defects in either enzyme would explain the impaired oxidation of '4C-labeled fatty and amino acids by intact MAD fibroblasts, and the observed normal or near normal ADH activities (10, 22, 25 MAD:S patients and three of the five MAD:M patients, confirming that either ETF or ETF-DH deficiency produces both MAD phenotypes (24, 25).
Methods
Chemicals. Substrates for mitochondrial oxidation studies were [1,5- '4Cjglutaric acid (2.5 mCi/mmol), [1-'4C] octanoic acid (4.7 mCi/mmol), Nuclear. The corresponding acyl-CoA esters were synthesized by the mixed anhydride method, as we described earlier (26) . Pure pig liver medium-chain ADH (MCADH) and ETF were gifts from Dr. Carole L. Hall (16) . Patient 1401 is a male neonate who died at 3 d of age with severe metabolic acidosis, hypoglycemia, and a characteristic MAD:S organic aciduria. Patient 840 is a 6-yr-old male who is neurologically devastated after a prolonged episode of seizures and acidotic coma; he excretes ethylmalonate and small amounts of glutarate and adipate. Patient 930 is a 4-yr-old male with growth failure and developmental delay whose urinary metabolite profile is similar to that of patient 840. Control fibroblast cultures were obtained from 11 normal individuals. Full clinical and biochemical descriptions of patients 1401, 840, and 930 will be published separately.
Fibroblasts were cultured in Eagle's minimal essential medium supplemented with 10% fetal bovine serum, 2 mM glutamine, 140MOM penicillin, 86 MuM streptomycin, and 162 gM neomycin. Fibroblasts were subcultured 1:4 every 2 wk and the media were changed weekly. Fibroblasts of passage 6-20 were used in all experiments.
Isolation ofmitochondria. Fibroblast mitochondria were isolated from three 750-cm2 glass roller bottles of each cell line by a method previously described (27) , except that digitonin treatment of the mitochondria was omitted. In all experiments, mitochondria from two control cell lines were assayed simultaneously with mitochondria from three to five MAD lines. Intact mitochondria were resuspended in a buffer consisting of KCI 100 mM, Tris-HCl 50 mM, pH 7.5, MgCl2 5 mM, ATP 1 mM, and EGTA 1 mM for '4C-substrate oxidation experiments. The oxidation of [1-14C] octanoate and -palmityl-CoA by intact mitochondria was performed in triplicate as described earlier (28) . For the oxidation of [ 1,5- '4C]glutarate (0.5 mM), 0.2 mM CoA, and 2.5 mM ATP were added to the incubation medium; with [1,4-'4C] succinate (2 mM), 2.5 mM ATP was added. These combinations of cofactors were selected to optimize oxidation of each substrate (data not shown).
For ADH and ETF assays, mitochondria were sonicated at 0°C for 30 s in 0.4-0.8 ml of 20 mM KP1, pH 7.6, using a Fisher sonic disrupter model 300 with a microtip (Fisher Scientific Co., Pittsburgh, PA); the sonicates were then centrifuged at 100,000 g for 1 h. Matrix glutamate dehydrogenase activity was assayed as described earlier (27) . The mitochondrial sonic supernatants (MS) were assayed for ADH and ETF as described below.
ADH assays. ADH activities were determined by both dye reduction and tritium-release assays. The dye reduction method follows the reduction of DCIP by endogenous ADH reduced by appropriate acyl-CoA substrates. The reaction is initiated by 440 pmol pig liver ETF (28) . The tritium-release assays for ADH activities were performed in duplicate as detailed previously using [2,3-3Hlacyl-CoA's as substrates (29) . Both methods use 0.1-0.5 mg of MS protein per assay.
Whole-cell sonic supernatants were obtained from two confluent 150-cm2 culture flasks for each cell line; cells were sonicated in 1.0-2.0 ml of 10 mM KP1, pH 7.6, containing 20 MM FAD, using a Fisher sonic disruptor, model 300, with a microtip at 0°C for 1 min, and centrifuged at 50,000 g for 20 min. The cell supernatant was used in tritium-release assays and the 3H20 formed from the substrates was quantitated by lyophilization, as previously described (29) .
ETF assays. Mitochondrial ETF activity was assayed by a modification of the dye reduction method used in previous assays for this en 
Results
Mitochondrial oxidation of'4C-labeled substrates. Intact MAD fibroblasts demonstrate blocked '4C-labeled fatty acid, branched chain amino acid, and lysine catabolism (1) (2) (3) (4) . We have also demonstrated defective '4C-labeled substrate oxidation in isolated fibroblast mitochondria (Table I ). These mitochondrial preparations have been purified 10-15-fold during isolation (27) . Glutamate dehydrogenase activities were similar in control and MAD MS, confirming that all mitochondrial preparations were of comparable purity (n 2 29; P > 0.15; data not shown). Mi Culture of diploid skin fibroblasts, mitochondrial isolation, and '4C-substrate oxidation studies were performed in triplicate as described earlier (22, 28) . The final concentration and specific activity of each substrate, and concentration of cofactors were as follows: [ Mitochondrial ADH activities. We have developed tritiumrelease assays for ADH activities in fibroblast preparations using [2,3-3H]acyl-CoA's as substrates (27, 29) . Enzymatic removal of tritium from carbons 2 and 3 ofthe substrate forms 3H20, which is separated quantitatively from unreacted substrate by anionexchange chromatography and lyophilization. Short-chain ADH (SCADH), MCADH, and isovaleryl-CoA dehydrogenase (IVDH) activities in MAD cell sonicates were measured using [2,3-3H]butyryl-, -octanoyl-, and -isovaleryl-CoA's as substrates and ranged from 63% to 128% of control (P > 0.2; data not shown). However, in MS, MCADH activities in three MAD:M lines were 70-74% and in the MAD:S cell lines as a group, 50% of control (P = 0.01; data not shown). MS IVDH activities were 66-82% and 61-73% ofcontrol in MAD:M and MAD:S lines, respectively (P > 0.1; Table II ). We also assayed MS ADH activities using a dye-reduction method we have described previously (27, 29) . SCADH activities were 58% and 80% of control in two MAD: M lines (P > 0.1) and averaged 52% for five MAD:S lines (Table  II; Because the proposed enzymatic defects in the MAD involve either ETF or ETF-DH, these lowered MAD:S ADH activities were not anticipated. Inasmuch as ETF or ETF-DH deficiency would block normal reoxidation ofADHs reduced by their substrates, increased turnover or relative instability of the reduced enzymes might explain these decreases. However, fibroblast MCADH reduced by octanoyl-CoA lost no activity after incubation at 37°C for 60 min, whereas enzyme incubated without substrate lost >70% of its initial activity over the same interval (Table III) ; incubating oxidized and reduced pig liver MCADH at both 37°C and 50°C gave qualitatively identical results (data not shown). Thus, interaction with the substrate appears to stabilize rather than destabilize this enzyme against thermal inactivation, possibly related to the protection by substrate of an essential cysteine residue located near the FAD-binding site (32) .
Mitochondrial ETF activities. Because ETF catalyzes the electron transfer from the reduced ADHs to ETF-DH in vivo, we reacted fibroblast MS ETF with pure pig liver MCADH and 50 ,M octanoyl-CoA. The reduced ETF then transfers its electrons to the electron acceptor dye DCIP, the rate of DCIP reduction reflecting ETF activity. The nonspecific reduction of DCIP by free CoASH derived from thioesterase-catalyzed acylCoA hydrolysis was inhibited by the sulfhydryl-alkylating agent NEM (30, 31) . To ensure maximal recovery of ETF activity, we assayed 0.88 and 2.5 pmol pig ETF with increasing amounts of pig liver MCADH; 2.5 pmol pig liver ETF produced rates of DCIP reduction similar to those in control MS. 165 pmol MCADH gave near maximal rates of DCIP reduction (Table  IV) . Because 495 pmol pig MCADH increased background DCIP reduction proportionately and did not greatly increase apparent ETF activity, we used 165 pmol MCADH in all ETF assays reported here.
Our assay system measured ETF activity accurately, inasmuch as we observed a linear increase in enzymatic activity with increasing concentrations of pure pig liver ETF (Fig. 2) with and without FAD in the same MS preparation were analyzed separately, activity in line 1430 still increased significantly (one-tailed P = 0.04).
To determine whether an ETF inhibitor was present in MAD mitochondria, equal volumes of control, MAD:S and/or MAD:M MS, were mixed pairwise, incubated at 30°C for 3 min, and assayed for ETF activity. In nine different combinations, observed ETF activities ranged from 82% to 1 12% of the predicted values, thereby excluding the existence of an ETF inhibitor in MAD MS (data not shown).
ETF activities in cell lines 1515, 1520, and 1540 are significantly greater than the other four MAD:S patients under all conditions ofassay (P < 0.01). Recently, Frerman and Goodman (25) found absent ETF-DH activity in these cell lines. Analogous to the lowered ADH activities found in all MAD:S cell lines (Table II) , the decreased ETF activities in these ETF-DH deficient lines could result from increased turnover and/or instability of ETF reduced by the ADH in vivo. However, both pig liver and control fibroblast MS ETF resisted thermal denaturation at 37°C in the reduced state for 60 min, whereas oxidized ETF lost up (Table  VI; other data not shown). The origin ofETF activity reductions in the ETF-DH-deficient lines remnains unclear. All the acyl-CoA's accumulated in the MAD are subsequently dehydrogenated in the mitochondrial matrix. For straight-chain fatty acids, this first reaction ofthe p3-oxidation spiral is catalyzed by the three flavoprotein ADHs, SCADH, MCADH, and LCADH, that oxidize short-, medium-, and long-chain fatty acylCoA's, respectively (30, 31, 33) . Other mitochondrial flavoprotein dehydrogenases include isovaleryl-CoA, 2-methyl branchedchain acyl-CoA, glutaryl-CoA, sarcosine, and dimethylglycine dehydrogenases; none of these eight enzymes share a common subunit (14, (34) (35) (36) . The first six ADHs are homotetramers (a4) containing four ionically bound FAD/mole (33-35; S. Goodman, personal communication), while sarcosine and dimethylglycine DH are monomers containing one covalently bound FAD/mole (36) . The reduced dehydrogenases are reoxidized by a second mitochondrial matrix enzyme, ETF (31, (37) (38) (39) . ETF then transfers electrons via ETF-DH to ubiquinone in the electron transport chain (40) (41) (42) .
We have assayed four ADHs in MAD cell and mitochondrial supernatants using both dye-reduction and tritium-release assays.
Both methods assay the ADHs accurately and the observed activities are not dependent on endogenous ETF or ETF-DH activities. In MAD cell supernatants, ADH activities were normal (>63% of control; P > 0.1) as measured by the tritium-release assay. In MAD:M mitochondrial supernatants, we generally found normal or near normal ADH activities. However, MAD: S ADH activities were moderately but significantly decreased and ranged from 38% to 73% of control depending on the cell line and activity considered. ADH activities in the ETF-deficient cell lines (1400, 1401, 1430, 1441) were identical to those in the ETF-DH deficient MAD:S lines (1515, 1520, and 1540; P > 0.2). These decreases are not explained by lability ofsubstrate-reduced ADH, in that octanoyl CoA reduction clearly stabilized, rather than destabilized, MCADH against thermal denaturation. Because no specific inhibitors of either ETF or ETF-DH have been identified that are compatible with long-term cell survival, we cannot model these ADH activity decreases in cultured fibroblasts.
Inasmuch as we alone have assayed the ADH in MAD:S fibroblast mitochondria, direct comparisons with the data of others remain difficult. However, some ADH assay results in whole cell homogenates substantiate our present observations. Frerman and Goodman (25) found that SCADH, MCADH, LCADH, and IVDH activities averaged 60-88% of control in cell homogenates from five MAD:S cell lines, four of which we also studied. Bennett With this assay, we found reduced ETF activity in all five MAD:M lines, and we have demonstrated profoundly deficient ETF activity (<6% of control) in four MAD:S lines. Combined with their clinical findings, whole cell and intact mitochondrial oxidations, and ADH activities, the biochemical etiology of MAD:S in these four patients is clearly ETF deficiency. In cell line 1400, derived from the first MAD:S patient (P.K.; 1), ETF activity was 3% of control. In earlier preliminary studies with this cell line, Rhead et al. (22) found normal ETF activity (159% of control). However, in those experiments, NEM was not used to sequester free CoASH produced by thioesterase-mediated octanoyl-CoA hydrolysis. This free CoASH in turn artefactually reduced DCIP, as evidenced by apparent ETF activities in control MS fourfold greater (22) than those found in this study (Table  V) . Using higher amounts of pig liver MCADH in these experiments (165 vs. 102 pmol flavin) also increased assay sensitivity.
Although deficient cellular riboflavin uptake, FAD synthesis, and/or mitochondrial FAD uptake could explain the ADH, ETF, and/or ETF-DH deficiencies ofthe MAD, incorporation of 14C-labeled riboflavin into FMN and FAD has been normal in kidney and/or fibroblast homogenates from several MAD:S patients (45, 46) . FAD Other important questions remain unanswered regarding the MAD. Because ETF-DH-deficient MAD:S patients are one of the few disorders of intermediary metabolism associated with disturbed morphogenesis, they represent a promising area for future investigations into the relationship of cellular energy metabolism and malformation syndromes. Although presumably secondary to the primary enzymatic defects, the moderately decreased ADH and ADH/ETF activities found in the ETF-and ETF-DH-deficient MAD:S cell lines, respectively, remain unexplained. We have shown that these decreases do not reflect shortterm instability of either ADH or ETF reduced by substrate. Unfortunately, there are no known specific in vivo inhibitors of ETF or ETF-DH to permit our studying these phenomena in intact normal fibroblasts. The available data confirm both the biochemical and phenotypic similarities between MAD:M and MAD:S and emphasize the enzymatic and molecular heterogeneity underlying defective electron transfer from the /3-oxidation spiral to the electron-transport chain.
